Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712770 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
ElectronicAdd to Basket
Live Chat Live Help Software for Website

Sonus Pharmaceuticals Inc: Premium Company Profile

Datamonitor, Jan 2008, Pages: 41


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Sonus Pharmaceuticalss main focus is to discover, develop and commercialize products for the treatment of diseases in the therapeutic area of oncology. The company seeks to build a franchise of oncology products through its own internal efforts.

Scope

- Contains corporate strategy, value chain presence and SWOT Analysis

- Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors

- Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights of this title

Sonus Pharmaceuticals is focused on the discovery, development and commercialization of pharmaceutical products for oncology indications. The company has only one program in its pipeline, namely, TOCOSOL Camptothecin, for the treatment of solid tumors.

Sonus derives its revenues from collaboration and licensing agreements. These revenues are related to the collaboration agreement with Bayer Schering, under which Bayer Schering was granted worldwide exclusive license to market and promote TOCOSOL Paclitaxel and was responsible for clinical development and regulatory activities outside of the US.

Sonus aims to apply its focus on advancing its second oncology product candidate, TOCOSOL Camptothecin, which was moved into a Phase I clinical trial in September 2006. In addition, it intends to identify and acquire products/technologies that are complementary to its focus in oncology in order to broaden the business and market opportunities.

Key reasons to purchase this title

- Access all the important information and analysis on the company in a single report

- Understand companys strengths, weaknesses, opportunities and threats along with business strategy and value chain

- Gain access to companys adjusted five year financial data along with key ratios and market capitalization




Customers who bought this item also bought

QLT Inc: Premium Company Profile

Imaging Agents - Global Strategic Business Report

Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities

The Pharma R&D Fact Book 2007

Men's Health Therapeutics Market to 2017 - Availability of Generic Sildenafil from 2012 to Restrain Market Growth

United States Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Multiple Sclerosis Therapeutics - Global Strategic Business Report

Animal Pharms Top Tier Companies: 2007 Edition

Martek Biosciences Corp: Premium Company Profile

Top 10 Healthcare Trends in 2011



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds